Navigation
Home
Advocating for Access
Background
Letters for Access
Press Releases For Access
Simplified Community Materials
Simplified Community Materials
Understanding your HCV infection
Community Led Reports
Country Information
Indonesia
India
Vietnam
Generic DAAs Pricing
Resources
Guidelines
Key Research Publication
Other Important Documents and Reports
News
Gallery
Photos
Video
Stories
Pricing and availability of generic Indian Ledipasvir and Sofosbuvir co-formulation as on 26 April 2016
Pricing and availability of generic Indian Ledipasvir and Sofosbuvir co-formulation as on 26 April 2016
Download PDF
May 3, 2016
/
News
Share
the Post
Related
Posts
Strategies to Secure Access to Generic HCV Medicines
Part 1: What is hepatitis C and how is it diagnosed?
The Updated Pricing of Ledipasvir and Sofosbuvir Co-formulated tablets
20 YEARS AFTER THE TRIPS AGREEMENT, U.S. GOVERNMENT SCORES MASSIVE VICTORY FOR BIG PHARMA IN TPP DEAL
Simplified HCV Treatment* for Treatment-Naive Patients Without Cirrhosis
IAC a community group in Indonesia demanding national food and drugs authority to expedite registration process of DAA medicines in Indonesia
Hepatitis C Treatment Snapshots: Daclatasvir
Updated Patent Situation on Key Products for Hepatitis C Treatment in Asia – August 2015
